At a glance
ClinicalIndex Comparison RecordN/AUnknown· 4,200 target
Drug / intervention
standard therapydrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
In Brief
An observational study evaluating standard therapy for Advanced Breast Cancer. Targeting 4,200 participants across 19 sites.
Detailed Summary
To study the epidemiological trends and characteristics for advanced breast cancer patients, to analyze these trends and report the results
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Breast Cancer
CountriesChina
Collaborators--
Timeline
N/AUnknownOverdue
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedFeb 2017
Primary CompletionApr 2017
Study CompletionDec 2017
TodayJul 2026
First PostedFeb 9, 2017
Enrollment StartApr 1, 2016
Primary CompletionApr 1, 2017
Study CompletionDec 1, 2017
TodayJul 1, 2026
Enrollment to primary: 1 yearPosted 9.4 years ago
Interventions
standard therapydrug
standard therapy for advanced/metastatic breast cancer